Content Reproduced verbatim from the Website of FindLaw, A Thomson Reuters Business, as permitted under their RSS FEEDS, Terms of Use.

Bayer Pharma AG v. Watson Laboratories, Inc., 16-2169

In a patent infringement action, the district court’s judgment for plaintiff Bayer is reversed where it clearly erred in determining that a skilled artisan would not have been motivated to create an oral disintegrating tablet version of an erectile dysfunction drug using specified sugar alcohols with the tablet formulated for immediate-release.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2017/11/01



  • United States Federal Circuit


WP Twitter Auto Publish Powered By :